Café

© 2026 Longbridge｜Terms of Service Privacy Policy

Biogen

BIIB

200.1401.01% ( -2.050 )

Closed: Jul 27, 16:00:00 (EDT)

OverviewOverview OptionsOptions NewsNews PostsPosts FinancialsFinancials ForecastForecast ValuationValuation ShareholdersShareholders ProfileProfile

LongbridgeAI

Biogen (BIIB) Reports Q2: Everything You Need To Know Ahead Of Earnings
Stock Story·3 hours ago
BIIB-1.01%
Orbimed Advisors LLC Makes New $11.29 Million Investment in Biogen Inc. $BIIB
Market Beat·20 hours ago
BIIB-1.01%
Biogen Inc. Stock Underperforms Wednesday When Compared To Competitors
MarketWatch Automated·Jul 22 at 03:57 PM
BIIB-1.01%
KBC Group NV Raises Stock Position in Biogen Inc. $BIIB
Market Beat·Jul 21 at 04:29 AM
BIIB-1.01%
Biogen Inc. Stock Underperforms Monday When Compared To Competitors
MarketWatch Automated·Jul 20 at 03:58 PM
BIIB-1.01%
Bank of New York Mellon Corp Lowers Stock Position in Biogen Inc. $BIIB
Market Beat·Jul 20 at 02:13 AM
BIIB-1.01%BNY-0.32%
Biogen Inc. Stock Underperforms Friday When Compared To Competitors
MarketWatch Automated·Jul 17 at 03:57 PM
BIIB-1.01%
Illinois Municipal Retirement Fund Grows Stock Holdings in Biogen Inc. $BIIB
Market Beat·Jul 16 at 04:52 AM
BIIB-1.01%
Synapticure Launches Groundbreaking Ataxia Care Program, Expanding Access to Specialized Neurology Nationwide | BIIB Stock News
StockTitan·Jul 15 at 10:47 PM
BIIB-1.01%
Biogen Inc. Stock Outperforms Competitors On Strong Trading Day
MarketWatch Automated·Jul 15 at 03:58 PM
BIIB-1.01%
LEQEMBI(R) Real-World LEADER Study Presented at AAIC(R) 2026 Finds Over 75% of Early Alzheimer's Patients Enrolled in the Study Remained Stable and Nearly 7% Improved Over an Average of 17 Months of Treatment
Japan Corporate News·Jul 15 at 01:50 PM
4523 BIIB-1.01%